- Home
- RSLS vs IBO Comparison
RSLS vs IBO Comparison
Compare RSLS & IBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RSLS
- IBO
- Stock Information
- Founded
- RSLS 2002
- IBO 2018
- Country
- RSLS United States
- IBO United States
- Employees
- RSLS N/A
- IBO N/A
- Industry
- RSLS Medical/Dental Instruments
- IBO
- Sector
- RSLS Health Care
- IBO
- Exchange
- RSLS Nasdaq
- IBO NYSE
- Market Cap
- RSLS 4.5M
- IBO 5.1M
- IPO Year
- RSLS 2007
- IBO 2024
- Fundamental
- Price
- RSLS $4.31
- IBO $0.51
- Analyst Decision
- RSLS Hold
- IBO
- Analyst Count
- RSLS 1
- IBO 0
- Target Price
- RSLS N/A
- IBO N/A
- AVG Volume (30 Days)
- RSLS 101.4K
- IBO 936.6K
- Earning Date
- RSLS 05-21-2025
- IBO 06-13-2025
- Dividend Yield
- RSLS N/A
- IBO N/A
- EPS Growth
- RSLS N/A
- IBO N/A
- EPS
- RSLS N/A
- IBO N/A
- Revenue
- RSLS $7,175,000.00
- IBO N/A
- Revenue This Year
- RSLS $52.80
- IBO N/A
- Revenue Next Year
- RSLS N/A
- IBO N/A
- P/E Ratio
- RSLS N/A
- IBO N/A
- Revenue Growth
- RSLS N/A
- IBO N/A
- 52 Week Low
- RSLS $4.03
- IBO $0.37
- 52 Week High
- RSLS $414.99
- IBO $6.17
- Technical
- Relative Strength Index (RSI)
- RSLS 34.73
- IBO N/A
- Support Level
- RSLS $4.34
- IBO N/A
- Resistance Level
- RSLS $4.95
- IBO N/A
- Average True Range (ATR)
- RSLS 0.53
- IBO 0.00
- MACD
- RSLS 0.19
- IBO 0.00
- Stochastic Oscillator
- RSLS 10.11
- IBO 0.00
About RSLS ReShape Lifesciences Inc.
Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus. Geographically, the company operates in the United States, Australia, Europe, and the Rest of world, and the majority of its revenue is generated from the United States.
About IBO IMPACT BIOMEDICAL INC
Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. Its technologies inlcude Linebacker, Laetose, 3F, and Equivir.